RFL is a subsidiary of the REL. Shivinder and his elder brother Malvinder were earlier the promoters of REL
The misappropriation came to light after an independent forensic audit was conducted by the new board
In October, the Sebi had directed Fortis to take necessary action to recover Rs 403 cr from Singh brothers
Malvinder had moved HC claiming access to pension funds as it was outside purview of attachment
Religare Finvest Ltd (RFL) is a subsidiary of Religare Enterprises Ltd (REL). At the end of December 2018, the Singh brothers were among the promoters of REL
Malvinder, in his complaint, said that if he did not agree to the demands of spiritual head of the Radha Soami Satsang Gurinder Singh Dhillon, he would be eliminated
Meanwhile, Religare has approached Delhi HC, accusing the two brothers of siphoning off money
Shivinder has denied the allegations as "false and fabricated", that it was the other way round and it was Malvinder who hit him
Shivinder asks NCLT to remove brother Malvinder from RHC Holding's board
Accuses Malvinder and Godhwani of oppression and mismanagement of group firms
Gurinder Singh Dhillon is a key character in the unravelling of the financial and health-care empire owned by the Singh brothers
Delhi HC asks Singh brothers to file for insolvency if they do not have money; seeks details of their bank accounts and transactions since 2016
Overexpansion, bad management, and multiple allegations irreparably taint Malvinder and Shivinder Singh
The main shareholder Singh brothers and their affiliates held an equity stake of 34.43 per cent in Fortis at the end of December
Enforces arbitration award related to the $4.6-bn sale of Ranbaxy
Daiichi Sankyo made its fourth attempt in the Delhi High Court on Monday to secure the assets of Malvinder Singh and Shivinder Singh (and their affiliate companies), after claiming that the former Ranbaxy promoters had made false statements in earlier affidavits tendered before the court. The affidavits in question had been submitted by the Singh brothers in line with directions issued on a petition seeking the enforcement of a Rs 2,562 crore Singapore arbitral award in favour of the Japanese pharma major.Senior advocate C A Sundaram, appearing on behalf of Daiichi began the Monday's proceedings by highlighting a Rs 1,500 crore discrepancy between the figures in the Singh brothers' affidavits and those provided in auditor reports of their holding company, RHC Holdings, submitted after a March 6 order made by the court. "Even today, there is no fair disclosure. The reports submitted by the auditors are completely different to the (Singh brothers') affidavits. They have committed ...
Former promoters of Ranbaxy tell Delhi HC they can pay fine to Daiichi